This inventor holds 1 USPTO granted patent. Top assignees: Guangdong Ocean University, Shenzhen Institute of Guangdong Ocean University. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 49 
1 out of 2 Years Active: 2025
Title: Yanmei Li: Innovator in Neuroinflammation Research
Introduction
Yanmei Li is a prominent inventor based in Zhaoqing, China. He has made significant contributions to the field of medicine, particularly in the prevention of neuroinflammation and cognitive disorders. His innovative work has the potential to impact clinical practices and improve patient outcomes.
Latest Patents
Yanmei Li holds a patent for the "Applications of butyrolactone-I in preparing medicine for preventing neuroinflammation and/or memory and cognitive disorders." This patent outlines the use of butyrolactone-I in the preparation of medicine aimed at preventing aluminum-induced neuroinflammation and cognitive disorders in zebrafish. The research demonstrates that butyrolactone-I may prevent neuroinflammation and enhance cognitive function through mechanisms such as antioxidation, inhibition of acetylcholinesterase activity, anti-inflammation, and regulation of intestinal flora. This innovative approach provides a feasible scheme for preventing neurodegenerative diseases in clinical medicine.
Career Highlights
Throughout his career, Yanmei Li has worked with esteemed institutions, including Guangdong Ocean University and the Shenzhen Institute of Guangdong Ocean University. His research has garnered attention for its potential applications in the medical field, particularly concerning neurodegenerative diseases.
Collaborations
Yanmei Li has collaborated with notable colleagues, including Yi Zhang and Yingying Nie. These partnerships have contributed to the advancement of his research and the development of innovative solutions in the field of neuroinflammation.
Conclusion
Yanmei Li's work in the field of neuroinflammation and cognitive disorders showcases his dedication to advancing medical science. His innovative patent on butyrolactone-I highlights the potential for new treatments in preventing neurodegenerative diseases. The impact of his research may lead to significant improvements in clinical practices and patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile